HCRT and Parkinson disease: Recent study showed that OX1R antagonist completely prevented orexin-A-induced neuroprotective effects against 6-OHDA-induced toxicity in SH-SY5Y cells (Pasban-Aliabadi et al., 2017) and a rat model of PD (Hadadianpour et al., 2017).